Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) Target Price at $16.79

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have received a consensus rating of “Hold” from the nine research firms that are presently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $16.7857.

A number of research analysts have commented on the company. UBS Group increased their price objective on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Leerink Partners upped their price target on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a “market perform” rating in a research note on Friday, September 5th. Zacks Research upgraded Pediatrix Medical Group to a “strong-buy” rating in a report on Monday, August 11th. Weiss Ratings reissued a “hold (c)” rating on shares of Pediatrix Medical Group in a report on Saturday, September 27th. Finally, Wall Street Zen upgraded shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday.

Institutional Trading of Pediatrix Medical Group

Institutional investors have recently bought and sold shares of the business. Principal Financial Group Inc. lifted its stake in shares of Pediatrix Medical Group by 6.2% in the 1st quarter. Principal Financial Group Inc. now owns 586,190 shares of the company’s stock valued at $8,494,000 after purchasing an additional 34,266 shares during the period. GAMMA Investing LLC grew its stake in shares of Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock worth $37,000 after purchasing an additional 1,765 shares during the period. SG Americas Securities LLC increased its holdings in Pediatrix Medical Group by 194.0% in the first quarter. SG Americas Securities LLC now owns 38,405 shares of the company’s stock valued at $556,000 after purchasing an additional 25,343 shares during the last quarter. Russell Investments Group Ltd. lifted its stake in Pediatrix Medical Group by 2.9% in the first quarter. Russell Investments Group Ltd. now owns 219,184 shares of the company’s stock valued at $3,176,000 after buying an additional 6,127 shares during the period. Finally, Strs Ohio bought a new position in Pediatrix Medical Group during the first quarter worth about $690,000. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Up 2.8%

MD opened at $17.52 on Friday. Pediatrix Medical Group has a 1-year low of $11.59 and a 1-year high of $17.77. The stock has a market capitalization of $1.53 billion, a PE ratio of 13.58 and a beta of 1.26. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. The firm has a 50-day moving average price of $15.82 and a two-hundred day moving average price of $14.41.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.42 by $0.11. The business had revenue of $468.84 million for the quarter, compared to analysts’ expectations of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. Pediatrix Medical Group’s revenue was down 7.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.34 earnings per share. As a group, equities analysts anticipate that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.